Search Clinical Trials
583,492 trials
ID
Status
Phase
Title
Sponsor
NCT07573969
Adding Dexmedetomidine Versus Ketamine to Bupivacaine in Fluoroscopy Guided Caudal Analgesia for Lumbosacral SurgeriesAin Shams UniversityRecruitingPhase 3
NCT07573969Recruiting
Phase 3
Adding Dexmedetomidine Versus Ketamine to Bupivacaine in Fluoroscopy Guided Caud...Ain Shams University
NCT07574177
Effects of Timed Restricted Eating on Body Composition, Metabolism, and Cardiovascular HealthUniversity of South AlabamaNot Yet RecruitingNot Applicable
NCT07574177Not Yet Recruiting
Not Applicable
Effects of Timed Restricted Eating on Body Composition, Metabolism, and Cardiova...University of South Alaba...
NCT07573345
Pain and Upper Extremity Function in Smartphone and Digital Game AddictionIstinye UniversityRecruiting
NCT07573345Recruiting
—
Pain and Upper Extremity Function in Smartphone and Digital Game AddictionIstinye University
NCT07572682
Effects of Dynamic Neuromuscular Stabilization (DNS) and Gyrotonic Training on Shoulder Function in Overhead AthletesSport University of TiranaCompletedNot Applicable
NCT07572682Completed
Not Applicable
Effects of Dynamic Neuromuscular Stabilization (DNS) and Gyrotonic Training on S...Sport University of Tiran...
NCT07572240
A Randomized, Open-Label, Parallel Proof-of-Concept Study to Assess the Effect of AP-Brain Collagen Peptides on the Improvement of Attention, Focus, and Memory in Stressed But Otherwise Healthy IndividualsRousselot BVBANot Yet RecruitingNot Applicable
NCT07572240Not Yet Recruiting
Not Applicable
A Randomized, Open-Label, Parallel Proof-of-Concept Study to Assess the Effect o...Rousselot BVBA
NCT07574242
Effect of vitk2 on Atopic Dermatitis Pediatrics PatientsOctober 6 UniversityCompletedNot Applicable
NCT07574242Completed
Not Applicable
Effect of vitk2 on Atopic Dermatitis Pediatrics PatientsOctober 6 University
NCT07572838
Alter-Ego as an Assistive Robotic Device.Istituti Clinici Scientifici Maugeri SpANot Yet Recruiting
NCT07573683
Additional Effect of Coherent Breathing With Aerobic Exercise on Cardiopulmonary Parameters and Quality of Life in Stage 1 Hypertensive IndividualsFoundation University IslamabadRecruitingNot Applicable
NCT07573683Recruiting
Not Applicable
Additional Effect of Coherent Breathing With Aerobic Exercise on Cardiopulmonary...Foundation University Isl...
NCT07573644
A Prospective Randomized Study Comparing the Safety of Percutaneous and Open Brachial Access in the Endovascular Treatment of Peripheral Arterial LesionUniversity Hospital, BrestNot Yet RecruitingNot Applicable
NCT07573644Not Yet Recruiting
Not Applicable
A Prospective Randomized Study Comparing the Safety of Percutaneous and Open Bra...University Hospital, Bres...
NCT07573241
Single Arm Trial Identifying Barriers and Facilitators to Mindfulness PracticeNational Center for Complementary and Integrative Health (NCCIH)Not Yet RecruitingNot Applicable
NCT07573241Not Yet Recruiting
Not Applicable
Single Arm Trial Identifying Barriers and Facilitators to Mindfulness PracticeNational Center for Compl...
NCT07573176
A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive DisorderJanssen Research & Development, LLCNot Yet RecruitingPhase 3
NCT07573176Not Yet Recruiting
Phase 3
A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Ma...Janssen Research & Develo...
NCT07572136
Phase I Dose Escalation Study of Anti-CRLF2-R/TSLPR Chimeric Antigen Receptor T Cells (TSLPR-CART) in Participants With Recurrent or Refractory CRLF2-R/TSLPR-Overexpressing B-cell Acute Lymphoblastic Leukemia (B-ALL)National Cancer Institute (NCI)Not Yet RecruitingPhase 1
NCT07572136Not Yet Recruiting
Phase 1
Phase I Dose Escalation Study of Anti-CRLF2-R/TSLPR Chimeric Antigen Receptor T...National Cancer Institute...
NCT07572526
tDCS: Sleep to Mood in Depression (S2M-D)NYU Langone HealthNot Yet RecruitingNot Applicable
NCT07572526Not Yet Recruiting
Not Applicable
tDCS: Sleep to Mood in Depression (S2M-D)NYU Langone Health
NCT07572123
Evaluating the Addition of Maintenance Immunotherapy Compared to the Usual Treatment of Chemotherapy and Autologous Stem Cell Transplant Alone for High-risk Patients With Relapsed or Refractory Hodgkin LymphomaNational Cancer Institute (NCI)Not Yet RecruitingPhase 2
NCT07572123Not Yet Recruiting
Phase 2
Evaluating the Addition of Maintenance Immunotherapy Compared to the Usual Treat...National Cancer Institute...
NCT07573748
Apple Vision Pro-Assisted Vascular Identification in Lung SurgeryThe Second People's Hospital of Huai'anNot Yet RecruitingNot Applicable
NCT07573748Not Yet Recruiting
Not Applicable
Apple Vision Pro-Assisted Vascular Identification in Lung SurgeryThe Second People's Hospi...
NCT07573332
A Safety and Tolerability Study of CC- 97540 (BMS-086353) in Anti-Aquaporin 4 Antibody Positive Neuromyelitis Optica PatientsBristol-Myers SquibbNot Yet RecruitingPhase 1
NCT07573332Not Yet Recruiting
Phase 1
A Safety and Tolerability Study of CC- 97540 (BMS-086353) in Anti-Aquaporin 4 An...Bristol-Myers Squibb
NCT07573358
Validation of Artificial Intelligence-Based Facial Paralysis Assessment in Patients With Bell's PalsyCairo UniversityNot Yet Recruiting
NCT07573358Not Yet Recruiting
—
Validation of Artificial Intelligence-Based Facial Paralysis Assessment in Patie...Cairo University
NCT07573579
Dynamic Voltage Mapping to Personalise the Ventricular Tachycardia SubstrateLiverpool Heart and Chest Hospital NHS Foundation TrustNot Yet RecruitingNot Applicable
NCT07573579Not Yet Recruiting
Not Applicable
Dynamic Voltage Mapping to Personalise the Ventricular Tachycardia SubstrateLiverpool Heart and Chest...
NCT07573436
Loncastuximab Tesirine and Rituximab as First-line Therapy in Patients With Post-transplant Lymphoproliferative Disorder (PLUTO)ADC Therapeutics S.A.Not Yet RecruitingPhase 1
NCT07573436Not Yet Recruiting
Phase 1
Loncastuximab Tesirine and Rituximab as First-line Therapy in Patients With Post...ADC Therapeutics S.A.
Result Breakdown
Not yet recruiting14 (70%)
Recruiting4 (20%)
Completed2 (10%)
not_applicable11 (55%)
Not Specified3 (15%)
Phase 13 (15%)
Phase 32 (10%)
Phase 21 (5%)